Guardant Health (GH) Capital Expenditures (2017 - 2026)

Guardant Health has disclosed Capital Expenditures across 10 years of filings, most recently posting $5.6 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $5.6 million, up 25.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.4 million (up 51.57% YoY), and the FY2025 annual result was $48.3 million, up 37.68% from the prior year.
• Capital Expenditures came in at $5.6 million for Q1 2026 at Guardant Health, down from $27.8 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $50.6 million in Q3 2022 to a low of -$11.1 million in Q4 2023.
• The 5-year median for Capital Expenditures is $6.0 million (2023), against an average of $10.1 million.
• Across the five-year window, Capital Expenditures jumped 285.99% in 2022 and slumped 211.29% in 2023, its largest moves.
• Guardant Health's Capital Expenditures stood at $10.0 million in 2022, then plunged by 211.29% to -$11.1 million in 2023, then soared by 269.59% to $18.9 million in 2024, then surged by 47.54% to $27.8 million in 2025, then sank by 79.96% to $5.6 million in 2026.
• The last three Capital Expenditures figures came in at $5.6 million (Q1 2026), $27.8 million (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.